top of page
Companies in the News
BlackThorn Therapeutics Announces Positive Phase 1 Results for Its Selective KOR Antagonist, BTRX-33
Phase 1 results and new translational data supporting the development of BTRX-335140 for neurobehavioral disorders presented at the Kappa...
Apr 2, 2019
Indigo Agriculture and Anheuser-Busch Partner To Meet Sustainability Goals for Rice Production
BOSTON--(BUSINESS WIRE)--Indigo Agriculture, a company dedicated to harnessing nature to help farmers sustainably feed the planet, and...
Mar 12, 2019
Beam Brings In $135M to Turn CRISPR Base Editing into Drugs
Beam Therapeutics made a splash last year when it launched with $87 million to develop medicines that use a more precise form of CRISPR...
Mar 7, 2019
Gossamer Bio pulls off $276M IPO to push a trio of programs through the clinic
Late last month, Gossamer Bio filed to raise up to $230 million in a fixed-price IPO so it could go public despite the partial shutdown...
Feb 9, 2019
Indigo Agriculture Launches Indigo Transport™, a Digital Logistics Platform to Expand Options for Gr
Indigo Transport is a full-service digital logistics platform designed to connect shippers and carriers for the efficient haul of...
Jan 30, 2019
BlackThorn Therapeutics Announces R&D Updates
BTRX-335140 Poised to Enter Phase 2 Efficacy Studies and BTRX-323511 to Enter IND-enabling Studies Company Increasing Investment in...
Jan 4, 2019
Indigo Ag, Inc. Acquires TellusLabs, a Leader in Satellite Technology and Artificial Intelligence, t
Indigo has acquired TellusLabs, a leader in the use of satellite technology and artificial intelligence whose mission is to build a...
Dec 14, 2018
Millendo Therapeutics Announces Successful Merger Completion
Merger with OvaScience Closed Shares of Combined Company to Commence Trading on the Nasdaq Capital Market Under New Symbol “MLND” on...
Dec 7, 2018
Vir Biotechnology and Alnylam Pharmaceuticals Initiate Phase 1/2 Study of VIR-2218
Novel investigational RNAi therapeutic for the treatment of chronic hepatitis B virus (HBV) infection Subject dosing commenced SAN...
Nov 30, 2018
bottom of page